Coronaropathies Valvulopathies
JESFC 2025

Infarctus et valvulopathies

Publié le jeudi 16 janvier 2025

Modérateur(s) :

Romain Capoulade , Jérémie Abtan

Orateur(s) :

Clément Boiteux , Stéphanie Barrere-Lemaire , Lauréline Boutonnet , Fabien Huet , Dimitri Bedo , Guillaume Guimbretiere , Gérémy Blot

Dans la session

Clément Boiteux SEMA3A is a predictive biomarker of primary ventricular fibrillation complicating STEMI
Stéphanie Barrere-Lemaire PPAR?/? preconditioning increased the cardioprotective effects of human MSC in IR injury
Lauréline Boutonnet Autologous mitochondrial transplantation as a strategy to prevent deleterious effects of peripheral ischemia-reperfusion
Fabien Huet Colchicine to prevent sympathetic denervation after acute myocardial infarction: the COLD-MI trial
Dimitri Bedo Cardio-renal butterfly effect: myocardial infarction with coronary reperfusion triggers kidney disease and induces interstitial fibrosis
Guillaume Guimbretiere Development of an orthoptic aortic valve replacement model in Yucatan minipig to study the degeneration of bioprosthetic valve
Gérémy Blot Modelling chronic kidney disease-induced cardiovascular calcifications in rats using an adenine/phosphate-enriched diet

Partager l'article :